Sutherland D E, Gillingham K, Moudry-Munns K C
Department of Surgery, University of Minnesota, Minneapolis.
Clin Transplant. 1991 Aug;5(4):330-41.
An outcome analysis was performed on pancreas transplants in the United States reported to the United Network for Organ Sharing (UNOS) Registry from its inception on 1 October 1987 to 21 October 1990 (n=1021). These cases comprise nearly one-third of the 3082 pancreas transplants reported to the International Pancreas Transplant Registry (1819 U.S., 1263 non-U.S.) from 1 December 1966 to 31 December 1990, including 619 in 1990 (528 U.S., 91 non-U.S.). Nearly all pancreas transplants in the U.S. during the 1987-90 period were by the bladder-drainage (BD) technique (92%). The overall patient and pancreas graft actuarial survival rates were 92% and 72% at 1 year. Patient survival rates were similar in all recipient categories, but pancreas graft survival rates were significantly higher (p less than 0.001) in recipients of a simultaneous pancreas and kidney (SPK) transplant (n=883) than in recipients of a pancreas after a kidney (PAK, n=112) or a pancreas transplant alone (PTA, n=71), being 77%, 52%, and 54%, respectively, at 1 yr. Kidney graft survival at 1 yr in U.S. SPK recipients was 86%. Most grafts (81%) were preserved in University of Wisconsin (UW) solution, and more than half were stored greater than 12 hours, with no difference in outcome with increasing duration of storage. At 1 yr, functional survival rates were 72% for U.S. pancreas grafts stored for either less than 12 (n=439), 12-24 (n=422), or 24-30 h (n=42). For grafts stored greater than 30 h (n=8), the 1-yr functional survival rate was 50% (p=ns versus the other storage times). On univariate analysis, no effect of HLA antigen mismatching on outcome for 1987-90 U.S. cases could be discerned. The results in the UNOS Registry were compared to the results for U.S. cases in the International Pancreas Transplant Registry performed between 1 January 1984 and 30 September 1987. In all recipient categories the pancreas graft functional survival rates were significantly higher in the 1987-90 (UNOS) than in the 1984-87 (pre-UNOS) era. A Cox multivariate analysis of 1984-90 cases showed the relative risk for pancreas graft loss to be significantly less (p less than 0.05) with bladder-drainage, with simultaneous transplantation of the kidney, with use of UW solution for preservation, and with 0-1 HLA-A, B, DR or 0 HLA-DR mismatches.(ABSTRACT TRUNCATED AT 400 WORDS)
对1987年10月1日登记开始至1990年10月21日向器官共享联合网络(UNOS)登记处报告的美国胰腺移植情况进行了结果分析(n = 1021)。这些病例占1966年12月1日至1990年12月31日向国际胰腺移植登记处报告的3082例胰腺移植的近三分之一(美国1819例,非美国1263例),其中1990年有619例(美国528例,非美国91例)。1987 - 1990年期间美国几乎所有胰腺移植(92%)采用膀胱引流(BD)技术。1年时患者和胰腺移植物的总体精算生存率分别为92%和72%。所有受者类别中的患者生存率相似,但同期胰腺 - 肾脏(SPK)移植受者(n = 883)的胰腺移植物生存率(77%)显著高于肾后胰腺(PAK,n = 112)或单纯胰腺移植(PTA,n = 71)受者,后两者1年时的生存率分别为52%和54%(p < 0.001)。美国SPK受者1年时肾移植物生存率为86%。大多数移植物(81%)用威斯康星大学(UW)溶液保存,超过一半保存时间超过12小时,保存时间延长对结果无差异。1年时,保存时间少于12小时(n = 439)、12 - 24小时(n = 422)或24 - 30小时(n = 42)的美国胰腺移植物功能生存率为72%。保存时间超过30小时(n = 8)的移植物1年功能生存率为50%(与其他保存时间相比p =无显著差异)。单因素分析显示,1987 - 1990年美国病例中HLA抗原错配情况对结果无影响。将UNOS登记处的结果与1984年1月1日至1987年9月30日国际胰腺移植登记处的美国病例结果进行比较。在所有受者类别中,1987 - 1990年(UNOS)的胰腺移植物功能生存率显著高于1984 - 1987年(UNOS之前)时期。对1984 - 1990年病例进行的Cox多因素分析显示,采用膀胱引流、同期移植肾脏、使用UW溶液保存以及HLA - A、B、DR错配0 - 1个或HLA - DR错配0个时,胰腺移植物丢失的相对风险显著降低(p < 0.05)。(摘要截选至400字)